Experimental drug trial seeks to improve treatment for head and neck cancer

24 Nov 2017
Cancer Research UK

Researchers want to find out whether using Astra Zeneca’s AZD1775 experimental compound, in combination with chemotherapy before surgery or with chemotherapy and radiotherapy after surgery, is more effective and reduces the risk of the cancer returning. 


Click here to read 'Cancer Research UK' news article in full